All guides

Recovery · ~3 min read

ARA-290: What It Is, How It Works & What the Research Shows

Overview

ARA-290 (cibinetide) is an 11-amino-acid peptide derived from erythropoietin (EPO). It activates the innate repair receptor, which drives EPO's tissue-protective and anti-inflammatory effects, without stimulating red blood cell production. Phase 2 human trials in sarcoidosis-related small fiber neuropathy and type 2 diabetes showed improvements in neuropathic pain and regrowth of small corneal nerve fibers.

Why researchers study it

Neuropathic pain

Reduced neuropathy symptoms in phase 2 human trials.

Nerve regrowth

Increased small corneal nerve fibers in sarcoidosis patients.

Tissue protection

Activates EPO's repair pathway without raising red blood cells.

How it works

Cibinetide is an erythropoietin-derived peptide designed to investigate tissue-protective signaling without the erythropoietic activity of full-length erythropoietin. Proposed receptor biology and clinical outcomes are distinct evidence questions.

Adamantane & the blood–brain barrier

Chemically attaching an adamantane group to a peptide can increase its lipid (fat) solubility. Researchers hypothesize that this modification may help certain compounds cross the tightly regulated blood–brain barrier. The effect depends on the specific modified molecule; greater lipid solubility alone does not establish brain delivery or clinical benefit. This does not apply automatically to the unmodified peptide and is not a reconstitution additive.

What the research shows

  • Small-fiber neuropathy symptoms and tissue-protective signaling have been studied.
  • Early human work has examined neuropathy-related outcomes, including in sarcoidosis.

Typical protocol

Reconstitute a 10 mg vial with 1 mL bacteriostatic water for 10 mg/mL. Typical range: 1–4 mg 1x daily · 5 on 2 off or daily.

Common stacks

  • ARA-290 + TB-500 — Pairs tissue-protective signaling with tissue-repair support.

Potential benefits & side effects

Potential benefits

  • Faster recovery from soft tissue injuries (tendons, ligaments, muscle)
  • Reduced inflammation and joint discomfort
  • Gut lining support (BPC-157 and KPV)
  • Improved skin quality and wound healing (GHK-Cu blends)

Side effects

  • Injection-site redness, itching or mild swelling
  • Temporary fatigue or lightheadedness
  • Headache or mild nausea
  • Copper-peptide blends can sting at the injection site

Lifestyle factors

  • Load gradually: healing tissue still needs controlled, progressive loading — don't rush back to max effort.
  • Sleep: most tissue repair happens during deep sleep.
  • Nutrition: protein, vitamin C and collagen-supporting foods help connective tissue rebuild.
  • Limit alcohol and smoking, which slow healing.
  • Rotate injection sites; some inject near (not into) the injured area.

Sources